FDA Inspection 845772 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program — FEI 2074237

The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on August 26, 2013 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)